Longitudinal analyses of anti-JCV antibody index for risk assessment of progressive multifocal leukoencephalopathy
{{output}}
Risk assessment for natalizumab-associated progressive multifocal leukoencephalopathy (Nat-PML) comprises the anti-JC virus (JCV) antibody index (AI). The anti-JCV AI was longitudinally determined in a natalizumab-treated MS cohort (Nat-MS, n = 468) and sample... ...
